Cite

HARVARD Citation

    Nitz, U. et al. (n.d.). P246 Risk assessment by St.Gallen 2013 recommendation and Oncotype DX®: results from the WSG PlanB trial. Breast. pp. S110-. [Online]. 
  
Back to record